+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Active Pharmaceutical Ingredient"

From
From
From
From
From
From
Excipients - Global Strategic Business Report - Product Thumbnail Image

Excipients - Global Strategic Business Report

  • Report
  • May 2026
  • 197 Pages
  • Global
From
Binder Excipients - Global Strategic Business Report - Product Thumbnail Image

Binder Excipients - Global Strategic Business Report

  • Report
  • May 2026
  • 194 Pages
  • Global
From
From
From
From
From
Sugar-Based Excipients - Global Strategic Business Report - Product Thumbnail Image

Sugar-Based Excipients - Global Strategic Business Report

  • Report
  • May 2026
  • 313 Pages
  • Global
From
Chiral Chemicals - Global Strategic Business Report - Product Thumbnail Image

Chiral Chemicals - Global Strategic Business Report

  • Report
  • May 2026
  • 196 Pages
  • Global
From
From
From
From
Empty Capsules - Global Strategic Business Report - Product Thumbnail Image

Empty Capsules - Global Strategic Business Report

  • Report
  • May 2026
  • 182 Pages
  • Global
From
Chiral Technology - Global Strategic Business Report - Product Thumbnail Image

Chiral Technology - Global Strategic Business Report

  • Report
  • May 2026
  • 183 Pages
  • Global
From
From
Loading Indicator

The Active Pharmaceutical Ingredient (API) market is a key component of the pharmaceutical manufacturing industry. APIs are the active ingredients in drugs that are responsible for their therapeutic effects. They are produced through chemical synthesis, biotechnological processes, or extraction from natural sources. APIs are then formulated into finished dosage forms such as tablets, capsules, and injectables. The API market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the drugs. The market is also highly competitive, with many companies vying for a share of the market. Companies in the API market are typically large, multinational corporations with extensive research and development capabilities. Some of the major players in the API market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more